A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 following Single and Multiple Ascending Dose Administration to Healthy Volunteers

Trial Identifier: D9090C00001
Sponsor: AstraZeneca
NCTID:: NCT04994106
Start Date: July 2021
Primary Completion Date: September 2022
Study Completion Date: September 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Japanese Translation

Trial Locations

Country Location
US, CA Glendale, CA, US, 91206